NCT01525797

Brief Summary

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
221

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2002

Completed
8.6 years until next milestone

First Submitted

Initial submission to the registry

May 11, 2011

Completed
9 months until next milestone

First Posted

Study publicly available on registry

February 3, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 4, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 4, 2013

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

11 years

First QC Date

May 11, 2011

Last Update Submit

January 23, 2026

Conditions

Liver Transplant Recipients

Keywords

Liver Transplant

Outcome Measures

Primary Outcomes (1)

  • Identify signatures predictive of graft rejection or tolerance.

    Analyze the pattern of gene expression in patients undergoing solid organ transplantation

    2 years

Study Arms (2)

Control

Rejection

Eligibility Criteria

Age17 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Liver Clinic

You may qualify if:

  • Received a liver Transplant

You may not qualify if:

  • Received Multiple Organ Transplant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor University Medical Center

Dallas, Texas, 752245, United States

Location

Study Officials

  • Goran Klintmalm, MD

    Baylor Health Care System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2011

First Posted

February 3, 2012

Study Start

October 15, 2002

Primary Completion

October 4, 2013

Study Completion

October 4, 2013

Last Updated

January 26, 2026

Record last verified: 2026-01

Locations

US(1)